{
    "clinical_study": {
        "@rank": "60437", 
        "arm_group": {
            "arm_group_label": "FSHD patient", 
            "arm_group_type": "Experimental"
        }, 
        "brief_summary": {
            "textblock": "The aim of the study was to compare the severity of illness between groups of patients\n      (Facio-Scapulo-Humeral Dystrophy = FHSD1, FSHD2 and patients both FSHD1 and FSHD2).\n\n      Despite advances in research on the subject, answers are still needed on these diseases.\n\n      We also aim to determine whether the chromosomal genetic  abnormality is involved in other\n      diseases and the frequency of this mutation in the population of patients FSHD.\n\n      This study will increase our knowledge of the two forms of FSHD who present a  common\n      pathophysiological mechanism and may occur together in the same family with a worsening of\n      the clinical phenotype worsening . In addition, epigenetic differences between FSHD type 1\n      and type 2 seems to have clinical consequences requiring appropriate management"
        }, 
        "brief_title": "Clinical, Genetic and Epigenetic Characterization of Patients With FSHD Type 1 and FSHD Type 2", 
        "condition": "Muscular Dystrophy, Facioscapulohumeral", 
        "condition_browse": {
            "mesh_term": [
                "Muscular Dystrophies", 
                "Muscular Dystrophy, Facioscapulohumeral"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  age \u2265 18 years and <75 years\n\n          -  FSHD patients 1 or 2 with or without genetic confirmation\n\n        Exclusion Criteria:\n\n        - Patient with all conditions considered by the investigator interfering with the proper\n        conduct of the study."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "75 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "100", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "October 23, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01970735", 
            "org_study_id": "13-AOI-01"
        }, 
        "intervention": {
            "arm_group_label": "FSHD patient", 
            "intervention_name": "Blood test", 
            "intervention_type": "Biological"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "December 10, 2013", 
        "location": {
            "contact": {
                "email": "sacconi.s@chu-nice.fr", 
                "last_name": "Sabrina SACCONI, Dr", 
                "phone": "+33 492039002"
            }, 
            "facility": {
                "address": {
                    "city": "Nice", 
                    "country": "France", 
                    "zip": "06202"
                }, 
                "name": "H\u00f4pital Archet 1"
            }, 
            "investigator": {
                "last_name": "Sabrina SACCONI, Dr", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_arms": "1", 
        "official_title": "Clinical, Genetic and Epigenetic Characterization of Patients With FSHD Type 1 and FSHD Type 2", 
        "overall_contact": {
            "email": "sacconi.s@chu-nice.fr", 
            "last_name": "Sabrina SACCONI, Dr", 
            "phone": "+33 492039002"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "France: Agence Nationale de S\u00e9curit\u00e9 du M\u00e9dicament et des produits de sant\u00e9", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "October 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "measure": "Muscle damage measure", 
                "safety_issue": "No", 
                "time_frame": "One time at the inclusion"
            }, 
            {
                "measure": "Level of muscle damage", 
                "safety_issue": "No", 
                "time_frame": "One time at the inclusion"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01970735"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Centre Hospitalier Universitaire de Nice", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Centre Hospitalier Universitaire de Nice", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "October 2013", 
        "study_design": "Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Basic Science", 
        "study_type": "Interventional", 
        "verification_date": "October 2013"
    }
}